$PM

Philip Morris International Inc.

5
2
0

No SEC Form 4 filings for $PM in the last 30 days.

See all $PM insider activity →
Med

PM vs. MO: The Smoke-Free Dividend Winner in This Tobacco Showdown

Philip Morris (PM) raised its quarterly dividend by 9% to $1.60, while Altria (MO) increased its dividend by 5% to $1.11. PM's revenue grew 10.4% in Q2, with 42% from smoke-free products. PM's adjusted EPS guidance for 2026 is $8.26-$8.41, reflecting 9.5%-11.5% growth. Altria's guidance is $5.61-$5.72, with 3.5%-5.5% growth. Altria offers a higher yield (6.15%) but faces declining cigarette volumes and $2.2B in e-vapor impairments.

This High-Yield Tobacco Stock Just Raised Its Dividend by 8.8%

Philip Morris International (PM) raised its dividend by 8.8% following strong Q2 results. Revenue rose 10.4% to $11.2B, with smoke-free products growing 11.7%. EPS increased 15.2% to $2.20. PM expects 5-7% organic revenue growth in 2026. Analysts anticipate Q3 EPS of $2.34, with a consensus 'Moderate Buy' rating and $207.07 target.

Trump administration plans to speed approvals of vapes and nicotine pouches - WSJ

The Trump administration plans to speed up approvals for smoke-free nicotine products like vapes and nicotine pouches, easing FDA review requirements. This benefits tobacco companies such as Altria (MO), Philip Morris (PM), and British American Tobacco (BTI), which face regulatory delays. The move aims to reduce illegal products but faces opposition from health advocates concerned about youth access.

PM sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 7 news stories mentioning PM (Philip Morris International Inc.). Coverage has skewed bullish: 5 bullish, 2 neutral, and 0 bearish.

Recent PM coverage spans corporate actions, financial news and earnings.

What's driving PM

AlphAI scores every news story that mentions PM with an AI model for sentiment and relevance, and aggregates insider trades from Philip Morris International Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PM

Score
$PMMed

PM vs. MO: The Smoke-Free Dividend Winner in This Tobacco Showdown

Philip Morris (PM) raised its quarterly dividend by 9% to $1.60, while Altria (MO) increased its dividend by 5% to $1.11. PM's revenue grew 10.4% in Q2, with 42% from smoke-free products. PM's adjusted EPS guidance for 2026 is $8.26-$8.41, reflecting 9.5%-11.5% growth. Altria's guidance is $5.61-$5.72, with 3.5%-5.5% growth. Altria offers a higher yield (6.15%) but faces declining cigarette volumes and $2.2B in e-vapor impairments.

$PMMed

This High-Yield Tobacco Stock Just Raised Its Dividend by 8.8%

Philip Morris International (PM) raised its dividend by 8.8% following strong Q2 results. Revenue rose 10.4% to $11.2B, with smoke-free products growing 11.7%. EPS increased 15.2% to $2.20. PM expects 5-7% organic revenue growth in 2026. Analysts anticipate Q3 EPS of $2.34, with a consensus 'Moderate Buy' rating and $207.07 target.

$MOMed

Trump administration plans to speed approvals of vapes and nicotine pouches - WSJ

The Trump administration plans to speed up approvals for smoke-free nicotine products like vapes and nicotine pouches, easing FDA review requirements. This benefits tobacco companies such as Altria (MO), Philip Morris (PM), and British American Tobacco (BTI), which face regulatory delays. The move aims to reduce illegal products but faces opposition from health advocates concerned about youth access.

$PMMed

UBS raises Philip Morris stock price target to $193 on ZYN pricing

UBS raised its price target on Philip Morris (PM) to $193, maintaining a Neutral rating. The stock trades at $189, above its Fair Value. UBS lowered its 2027 ZYN sales growth forecast to 3% from 19% due to pricing changes. PM plans to reduce ZYN pouch count per can by 25%. UBS cut its 2027 group organic sales growth estimate to 6.4% from 6.9%. PM's dividend yield is 3.4%, with 18 consecutive years of increases. Stifel reiterated a Buy rating with a $205 target, citing smoke-free product growth.

$MOLow

Can Altria's on! Build Share as Nicotine Pouches Keep Growing?

Altria's on! brand saw its share of the U.S. oral tobacco category rise 8.6% in Q2 2026, with first-half volume up 5.1% to 96.1M cans. The nicotine pouch category grew to 59.9% of the oral tobacco market, driven by on! PLUS expansion to 120,000 stores. Competitors like Philip Morris and Turning Point Brands also reported growth in this segment. Altria's stock gained 6.5% in six months, trading at a forward P/E of 11.82X.

$PMLow

Trump’s Surgeon General Pick Loves These 3 Tobacco Stocks

Philip Morris (PM) has a consensus 'Moderate Buy' rating with a $206.43 price target, implying 6% upside. Altria Group (MO) gained 22% YTD, with a $69.58 consensus target. British American Tobacco (BTI) has a 22% upside target amid restructuring and smokeless product growth.

Related tickers